EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Additive Effects of N-Acetylcysteine and [R4W4] Combination Treatment on Mycobacterium avium

Kayvan Sasaninia iD, Iffat Hasnin Era, Nezam Newman, Jesse Melendez, Wajiha Akif, Eashan Sharma, Omid Nikjeh, Ira Glassman iD, Cristián Jiménez, Navya Sharma, Ama Xu, Maria Lambros und 3 weitere

International Journal of Molecular Sciences · 24.10.2025 · 26 (21) · 10361

DOI: 10.3390/ijms262110361 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.10.2025. Verfasst von Kayvan Sasaninia und 14 weiteren Autor:innen. Beteiligte Einrichtung: College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA. Hauptthemen laut MEDLINE: Acetylcysteine, Mycobacterium avium, Anti-Bacterial Agents, Peptides, Cyclic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Potts Memorial Foundation and NIH-NHLBI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacterium avium is an opportunistic pathogen and a leading contributor to nontuberculous mycobacterial infections in immunocompromised individuals. However, treatment duration, antibiotic toxicity, and resistance present challenges in the management of mycobacterium infections, prompting the need for novel treatment. N-acetylcysteine (NAC) has demonstrated potent antimycobacterial activity, while antimicrobial peptides such as the cyclic [R4W4] have shown additive effects when combined with first-line antibiotics. This study aimed to investigate the mechanism and efficacy of NAC and [R4W4] combination therapy against M. avium. A membrane depolarization assay was used to evaluate the effects of NAC and [R4W4] on M. avium cell membrane integrity. Antimycobacterial activity was assessed by treating cultures with varying concentrations of NAC, [R4W4], a combination, or a sham treatment. The same regimens were applied to M. avium-infected THP-1-derived macrophages to assess intracellular efficacy. NAC and [R4W4] each disrupted the M. avium membrane potential, with enhanced effects in combination. The combination treatment significantly reduced M. avium survival in both the culture and infected macrophages compared with NAC alone and untreated controls. [R4W4] and NAC also demonstrated potent antibacterial activity, while the lowest MIC and the combination of [R4W4] and NAC displayed additive effects, indicating an improved bacterial inhibition compared to individual treatments. These findings demonstrate the additive activity of NAC and [R4W4] against M. avium in vitro and suggest that combining antioxidant compounds with antimicrobial peptides may represent a promising strategy for treating mycobacterial infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetylcysteineMycobacterium aviumAnti-Bacterial AgentsPeptides, CyclicHumansMicrobial Sensitivity TestsMacrophagesDrug SynergismTHP-1 CellsDrug Therapy, CombinationMembrane Potentials

Stichwörter der Autor:innen

AMPsCFUM. aviumMACNACTHP-1[R4W4]cyclic peptide

Substanzen

AcetylcysteineAnti-Bacterial AgentsPeptides, Cyclic

Autor:innen und Institutionen

  • College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA.
  • College of Health Sciences, Western University of Health Sciences, Pomona, CA 91766, USA.
  • College of Science, California State Polytechnic State University, Pomona, CA 91768, USA.
  • Crean College of Health Sciences, Chapman University, Orange, CA 92866, USA.
  • College of Natural and Agricultural Sciences, University of California, Riverside, CA 92521, USA.
  • College of Pharmacy, Western University of Health Sciences, Pomona, CA 91766, USA.

ORCID-Profile: Kayvan Sasaninia, Ira Glassman, Miou Zhou, Rakesh Tiwari, Vishwanath Venketaraman

Förderung

  • Potts Memorial Foundation and NIH-NHLBI

Zitieren

APA

Sasaninia, K., Era, I. H., Newman, N., Melendez, J., Akif, W., Sharma, E., Nikjeh, O., Glassman, I., Jiménez, C., Sharma, N., Xu, A., Lambros, M., Zhou, M., Tiwari, R., & Venketaraman, V. (2025). Additive Effects of N-Acetylcysteine and [R4W4] Combination Treatment on Mycobacterium avium. International Journal of Molecular Sciences, 26(21), 10361. https://doi.org/10.3390/ijms262110361

Vancouver

Sasaninia K, Era IH, Newman N, Melendez J, Akif W, Sharma E, et al. Additive Effects of N-Acetylcysteine and [R4W4] Combination Treatment on Mycobacterium avium. International Journal of Molecular Sciences. 2025;26(21):10361. doi:10.3390/ijms262110361

BibTeX
@article{Sasaninia2025,
  author = {Sasaninia, Kayvan and Era, Iffat Hasnin and Newman, Nezam and Melendez, Jesse and Akif, Wajiha and Sharma, Eashan and Nikjeh, Omid and Glassman, Ira and Jiménez, Cristián and Sharma, Navya and Xu, Ama and Lambros, Maria and Zhou, Miou and Tiwari, Rakesh and Venketaraman, Vishwanath},
  title = {Additive Effects of N-Acetylcysteine and [R4W4] Combination Treatment on Mycobacterium avium},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {21},
  pages = {10361},
  doi = {10.3390/ijms262110361}
}
Kostenlos starten →